Nitra, an AI-native operating platform designed to help healthcare practices manage administrative and financial operations, announced $187 million in financing across its Series A and Series B rounds, venture debt, and a warehouse facility. The latest funding brings the company’s total capital raised to $205 million, including $90 million in equity.
The financing follows a period of rapid growth for the company, which reported revenue expansion of more than 740 percent in 2025 and surpassed $1 billion in annualized processing volume across its platform. Nitra is targeting $4 billion in annualized processing volume in 2026 as adoption accelerates among healthcare providers seeking automation tools for back-office operations.
The funding includes $72 million in new equity, consisting of a $50 million Series B round and a previously undisclosed $22 million Series A completed in August 2025. Investors participating in the equity rounds include Actions Capital, AppWorks, Comma Capital, Dunamu & Partners, Era Funds, New Enterprise Associates (NEA), Pantera Capital, and Sazze Partners. Additional participation came from AAF, Gaingels, Hyphen Capital, K8, Mana Ventures, Necessary Ventures, PIDC/Uni-President, Purestone Silks, SignalRank, Simu Liu’s Markham Valley Ventures, Soma Capital, and other investors.
In addition to equity financing, Nitra secured $20 million in venture debt from Avenue Capital Group and expanded a warehouse credit facility to $95 million with Treville Capital Group and Encina Lender Finance.
Founded in 2024 by CEO Tim Hwang and President Jonathan Chen, Nitra aims to address operational inefficiencies in the U.S. healthcare system, where administrative costs account for roughly 25 percent of the nearly $5.9 trillion spent annually. The company’s platform embeds AI agents into core business workflows for medical practices, consolidating functions such as payments, procurement, inventory management, scheduling, and insurance verification into a single system.
Nitra’s platform currently includes financial automation tools, including a Visa-powered expense card, expense management, bill pay, patient payment processing, and AI-driven accounting automation tailored for healthcare providers. The company also offers a commerce and inventory marketplace that connects practices to thousands of biopharmaceutical and medical equipment products through partnerships with companies such as McKesson and Medline. AI procurement agents manage supplier interactions, negotiate pricing, onboard vendors, execute purchases, and track inventory across the supply chain.
The company recently launched a patient management module that introduces voice AI agents capable of handling appointment scheduling and insurance eligibility checks. The system integrates patient communication, benefits verification, and scheduling directly into practice operations, helping reduce administrative burdens for physicians and staff.
Nitra’s platform is now used by thousands of doctors across more than 700 clinics. In December 2025 alone, the system processed approximately $9 million in biopharmaceutical and medical purchases in a single day. Annualized revenue increased from $4 million to more than $33 million during 2025.
Looking ahead, the company expects to expand its customer base to more than 3,000 clinics, exceed $150 million in annualized revenue, and surpass $4 billion in annualized processing volume in 2026. As part of its expansion plans, Nitra intends to grow its workforce from about 50 employees last year to more than 200 by the end of 2026. The company is also developing additional AI modules focused on revenue cycle management, patient marketing, payroll, and staffing.
In conjunction with the financing announcement, Dr. Richard Park, founder and former CEO of CityMD, has joined Nitra’s board of directors. Park previously led CityMD through its merger with Summit Health and the combined company’s $8.9 billion acquisition by VillageMD, which is owned by Walgreens.
Nitra previously raised a seed round in 2022 from investors including Andreessen Horowitz, NEA, Pantera Capital, KB Financial Group, Jerry Yang’s AME Cloud Ventures, Gold House Ventures, Primer Sazze, Dreamers VC, Sparklabs, Expa, Era, Comma Capital, and Dunamu & Partners.
KEY QUOTES:
“We’re on a mission to serve the people that serve our communities and help doctors save time and money. Practices are running critical workflows across disconnected systems that were never designed to work together. Nitra brings those layers together into a single AI-native operating system that helps healthcare practices run their operations more efficiently.”
Tim Hwang, CEO of Nitra
“Nitra is creating a new category of platform for healthcare practices. From the beginning, we viewed the fintech entry point as the wedge into a much larger opportunity to build the AI-native operating platform for healthcare providers. Since our seed investment, the Nitra team has consistently executed on that vision. As someone who regularly speaks with clinicians and practice owners, it’s clear there is a strong demand for modern financial and operational infrastructure purpose-built for healthcare practices. This round positions Nitra to deepen that platform and expand the capabilities providers rely on every day.”
Adarsh Bhatt, General Partner at Comma Capital
“Providing $20 million in venture debt reflects our conviction in the Nitra team and the company’s momentum. Tim Hwang and Jonathan Chen are exceptional founders with a strong track record of building and scaling ambitious platforms, and we believe Nitra is well positioned to become critical infrastructure for healthcare practices.”
Dan Holman, Senior Portfolio Manager for Avenue Capital Group’s Growth Lending Strategy
